Cancer statistics, 2016

Cited by (1,071)

Items 801–900 of 1,071

1. Z-ligustilide: A review of its pharmacokinetics and pharmacology.
   Qingxuan Xie, Linlin Zhang, Long Xie, Yu Zheng, Kai Liu, Hailong Tang, Yanmei Liao, Xiaofang Li · 2020 · Phytotherapy Research
2. 5′-tRF-GlyGCC: a tRNA-derived small RNA as a novel biomarker for colorectal cancer diagnosis
   Yingmin Wu, Xiangling Yang, Guanmin Jiang, Haisheng Zhang, Lichen Ge, Feng Chen, Jiexin Li, Huanliang Liu, Hongsheng Wang · 2021 · Genome Medicine
3. The landscape of driver mutations in cutaneous squamous cell carcinoma
   Darwin Chang, Alan Hunter Shain · 2021 · npj Genomic Medicine
4. Cohesin mutations in human cancer
   Victoria K. Hill, Jung-Sik Kim, Todd A. Waldman · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
5. Oncolytic Virotherapy for the Treatment of Malignant Glioma
   Paul M. Foreman, Gregory K. Friedman, Kevin A. Cassady, James M. Markert · 2017 · Neurotherapeutics
6. Bitter melon extract inhibits breast cancer growth in preclinical model by inducing autophagic cell death
   Naoshad Muhammad, Robert Steele, Timothy Scott Isbell, Nancy Philips, Ratna B. Ray · 2017 · Oncotarget
7. DNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer
   Catherine Leygo, Marissa Williams, Hongchuan Jin, Michael W.Y. Chan, Wai Kit Chu, Michael Grusch, Yuen Yee Cheng · 2017 · Disease Markers
8. Pharmacological Inhibition of LSD1 for Cancer Treatment
   Guan‐Jun Yang, Pui-Man Lei, Suk-Yu Wong, Dik‐Lung Ma, Chung‐Hang Leung · 2018 · Molecules
9. LncRNAs in ovarian cancer
   Jinyan Wang, Ai-qing Lu, Lijuan Chen · 2018 · Clinica Chimica Acta
10. Medication-related osteonecrosis of the jaw: A literature review
    Shinichiro Kuroshima, Muneteru Sasaki, Takashi Sawase · 2019 · Journal of Oral Biosciences
11. AIE-featured tetraphenylethylene nanoarchitectures in biomedical application: Bioimaging, drug delivery and disease treatment
    Kothanahally S. Sharath Kumar, Yarabahally R. Girish, Milad Ashrafizadeh, Sepideh Mirzaei, Kadalipura Puttaswamy Rakesh, Mohammad Hossein Gholami, Amirhossein Zabolian, Kiavash Hushmandi, Gorka Orive, Firoz Babu Kadumudi et al. · 2021 · Coordination Chemistry Reviews
12. Predicting endometrial cancer subtypes and molecular features from histopathology images using multi-resolution deep learning models
    Hong, Runyu, Liu, Wenke, DeLair, Deborah, Razavian, Narges, Fenyö, David · 2021 · Cell Reports Medicine
13. Skin Cancer Screening: Recommendations for Data-Driven Screening Guidelines and a review of the US Preventive Services Task Force Controversy
    Mariah Johnson, Sancy Ann Leachman, Lisa G. Aspinwall, Lee D. Cranmer, Clara N. Curiel‐Lewandrowski, Vernon K. Sondak, Clara E. Stemwedel, Susan M. Swetter, John T. Vetto, Tawnya Lynn Bowles et al. · 2017 · Melanoma Management
14. Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles
    Xiangyi Li, Yingjie Xu, Hui Song Cui, Tao Huang, Disong Wang, Baofeng Lian, Wěi Li, Guangrong Qin, Lanming Chen, Lu Xie · 2017 · Artificial Intelligence in Medicine
15. Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer
    Qi Zhang, Yu Lou, Jingying Zhang, Qihan Fu, Tao Wei, Xu Sun, Qi Chen, Jiaqi Yang, Xueli Bai, Tingbo Liang · 2017 · Molecular Cancer
16. Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non–muscle-invasive Bladder Cancer
    Jose Luis Dominguez-Escrig, B. Peyronnet, Thomas Seisen, Harman Maxim Bruins, Cathy Yuhong Yuan, Marko M. Babjuk, Andreas Böhle E, Maximilian Burger, Éva Compérat, Paolo Gontero et al. · 2017 · European Urology Focus
17. Path R-CNN for Prostate Cancer Diagnosis and Gleason Grading of Histological Images
    Wenyuan Li, Jiayun Li, Karthik V. Sarma, King Chung Ho, Shiwen Shen, Beatrice S. Knudsen, Arkadiusz Gertych, Corey W Arnold · 2018 · IEEE Transactions on Medical Imaging
18. Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies
    Archu Singh, Yub Raj Neupane, Bharti Mangla, Kanchan Kohli · 2019 · Journal of Pharmaceutical Sciences
19. Red blood cell membrane-coated upconversion nanoparticles for pretargeted multimodality imaging of triple-negative breast cancer
    Mengting Li, Hanyi Fang, Qingyao Liu, Yongkang Gai, Lujie Yuan, Sheng Wang, Huiling Li, Yi Hou, Mingyuan Gao, Xiaoli Lan · 2020 · Biomaterials Science
20. CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging
    Gary A. Ulaner, Nicholas B. Sobol, Joseph A. O’Donoghue, Assen S. Kirov, Christopher C. Riedl, Ryan K Min, Eric Smith, Lukas M. Carter, Serge K. Lyashchenko, Jason Stuart Lewis et al. · 2020 · Radiology
21. PGMD/curcumin nanoparticles for the treatment of breast cancer
    Mankamna R. Kumari, Nikita Sharma, Romila Manchanda, Nidhi Gupta, Asad Syed, Ali Hassan Bahkali, Surendra Nimesh · 2021 · Scientific Reports
22. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis
    Robert W. Holloway, Sarika Gupta, Nicole M. Stavitzski, Xiang Zhu, Erica L. Takimoto, Ajit Gubbi, Glenn E. Bigsby, Lorna A. Brudie, James Erasmus Kendrick, Sarfraz Ahmad · 2016 · Gynecologic Oncology
23. NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction
    Chao Zhang, Hui-Jie Wang, Qichao Bao, Lei Wang, Tian-kun Guo, Weilin Chen, Lili Xu, Hai-Shan Zhou, Jinlei Bian, Yingrui Yang et al. · 2016 · Oncotarget
24. Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN
    L. Chow, C. Morishima, K. Eaton, C. Baik, Bernardo H. L. Goulart, L. Anderson, K. Manjarrez, G. Dietsch, J. K. Bryan, R. Hershberg et al. · 2016 · Clinical Cancer Research
25. Exploring the pharmacological mechanism of Yanghe Decoction on HER2-positive breast cancer by a network pharmacology approach
    Liuting Zeng, Kailin Yang · 2017 · Journal of Ethnopharmacology
26. Rose hip as an underutilized functional food: Evidence-based review
    Seema V. Patel · 2017 · Trends in Food Science & Technology
27. Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma
    John C. S. Chang, Madappa N. Kundranda · 2017 · International Journal of Molecular Sciences
28. Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?
    Isabella M. Frigerio, Paolo Regi, Alessandro Giardino, Filippo Scopelliti, Roberto Girelli, Claudio Bassi, Stefano Gobbo, Paolo Tinazzi Martini, Paola Capelli, Mirko D’Onofrio et al. · 2017 · Annals of Surgical Oncology
29. Pharmacokinetics, Biodistribution, and Radiation Dosimetry for 89Zr-Trastuzumab in Patients with Esophagogastric Cancer
    Joseph A. O’Donoghue, Jason Stuart Lewis, Neeta D. Pandit-Taskar, Stephen E. Fleming, Heiko M. Schöder, Steven M. Larson, Volkan Beylergil, Shutian Ruan, Serge K. Lyashchenko, PAT B. ZANZONICO et al. · 2017 · Journal of Nuclear Medicine
30. Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer
    Jianfeng Liu, Lei Wu, Leilei Yang, Weiwei Deng, Liang Mao, Hao Wu, Wen‐Feng Zhang, Zhi‐Jun Sun · 2018 · Journal of Experimental & Clinical Cancer Research
31. Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy
    Xin Li, Zili Liu, Yutuan Wu, He Wu, Wei Dai, Bilal Arshad, Zhou Xu, Hao Li, Kainan Wu, Lingquan Kong · 2018 · Lipids in Health and Disease
32. Association of Prevalence of Benign Pathologic Findings After Partial Nephrectomy With Preoperative Imaging Patterns in the United States From 2007 to 2014
    Jae Heon Kim, Shufeng Li, Yash Samir Khandwala, Kyung Jin Chung, Hyung Keun Park, Benjamin Inbeh Chung · 2018 · JAMA Surgery
33. Cytoreductive Surgery With or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial
    Cascales Campos Pedro Antonio, González Gil Alida, Gil Gómez Elena, González Sánchez Rocío, Martínez García Jerónimo, José Luis Alonso-Romero, Aníbal Nieto Díaz, Francisco Barceló Valcárcel, Gómez Ruiz Álvaro Jesús, Pablo Ramírez-Romero et al. · 2021 · Annals of Surgical Oncology
34. Squamous cell carcinoma of the urinary bladder: Systematic review of clinical characteristics and therapeutic approaches
    Jeremy W. Martin, Estrella M. Carballido, Ahmed Ahmed, Bilal Farhan, Rahul Dutta, Cody Smith, Ramy F. Youssef · 2016 · Arab Journal of Urology
35. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide
    Dongzhi Yang, Liangzhu Feng, Casey A. Dougherty, Kathryn E. Luker, Daiqin Chen, Meagan A. Cauble, Mark M. Banaszak Holl, Gary D. Luker, Brian Dale Ross, Zhuang Liu et al. · 2016 · Biomaterials
36. Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles
    David T. Hoang, Kenneth A. Iczkowski, Deepak Kilari, William A. See, Marja T. Nevalainen · 2016 · Oncotarget
37. Current perspectives on CHEK2 mutations in breast cancer
    Panagiotis Apostolou, Ioannis Papasotiriou · 2017 · Breast Cancer Targets and Therapy
38. Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152
    Zhen Li, Yan Li, Ya Li, Kewei Ren, Xin Li, Xinwei Han, Jiaxiang Wang · 2017 · Journal of Biochemical and Molecular Toxicology
39. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research Brain Metastases Working Group
    NU Lin, Tatiana Michelle Prowell, Antoinette R. Tan, Marina Kozak, Oliver Rosen, Laleh Amiri‐Kordestani, Julia R. White, Joohee Sul, Louise M. Perkins, K. Beal et al. · 2017 · Journal of Clinical Oncology
40. Xanthohumol inhibits angiogenesis by suppressing nuclear factor‐κB activation in pancreatic cancer
    Kenta Saito, Yoichi Matsuo, Hiroyuki Imafuji, Tomotaka Okubo, Yuzo Maeda, Takafumi Sato, Tomoya Shamoto, Ken Tsuboi, Mamoru Morimoto, Hiroki Takahashi et al. · 2017 · Cancer Science
41. Factors That Contribute to Differences in Survival of Black vs White Patients With Colorectal Cancer
    Helmneh M. Sineshaw, Kimmie Ng, W. Dana Flanders, Otis Webb Brawley, Ahmedin Jemal · 2017 · Gastroenterology
42. Recruitment of CCR2 + tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer
    Julie G. Grossman, Timothy M. Nywening, Brian A. Belt, Roheena Z. Panni, Bradley Aaron Krasnick, David G. DeNardo, William G. Hawkins, Simon Peter Goedegebuure, David C. Linehan, Ryan Courtney Fields · 2018 · OncoImmunology
43. Plasmonic and Photothermal Immunoassay via Enzyme-Triggered Crystal Growth on Gold Nanostars
    Yahua Liu, Min Pan, Wenxiao Wang, Qunying Jiang, Fuan Wang, Dai‐Wen Pang, Xiaoqing Liu · 2018 · Analytical Chemistry
44. An overview on Vadimezan (DMXAA): The vascular disrupting agent
    Daei Farshchi Adli, Amir, Jahanban‐Esfahlan, Rana, Seidi, Khaled, Samandari‐Rad, Sonia, Zarghami, Nosratollah · 2018 · Chemical Biology & Drug Design
45. Afatinib restrains K-RAS–driven lung tumorigenesis
    Moll, Herwig P., Pranz, Klemens, Musteanu, Monica, Grabner, Beatrice, Hruschka, Natascha, Mohrherr, Julian, Aigner, Petra, Stiedl, Patricia, Brcic, Luka, Laszlo, Viktoria et al. · 2018 · Science Translational Medicine
46. Significance of Serum Total Oxidant/Antioxidant Status in Patients with Colorectal Cancer
    Rong Wu, Jiafu Feng, Yuwei Yang, Chunmei Dai, Anyang Lu, Jie Li, Yao Liao, Miao Xiang, Qingmei Huang, Dong Wang et al. · 2017 · PLoS ONE
47. Regulation of ITGA 3 by the anti‐tumor miR‐199 family inhibits cancer cell migration and invasion in head and neck cancer
    Keiichi Koshizuka, Toyoyuki Hanazawa, Naoko Kikkawa, Takayuki Arai, Atsushi Okato, Akira Kurozumi, Mayuko Kato, Koji Katada, Yoshitaka Okamoto, Naohiko Seki · 2017 · Cancer Science
48. Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas
    Opal L. Reddy, Peter I. Shintaku, Neda A. Moatamed · 2017 · Diagnostic Pathology
49. Hair disorders in patients with cancer
    Azael Freites‐Martínez, Jerry Shapiro, Shari Beth Goldfarb, Julie R. Nangia, Joaquin Juan Jimenez, Ralf Paus, Mario E. Lacouture · 2018 · Journal of the American Academy of Dermatology
50. Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP)
    Masturah Bte Mohd Abdul Rashid, Tan Boon Toh, Lissa Hooi, Aleidy Silva, Yanzhou Zhang, Pei Fang Tan, Ai Ling Teh, Neerja Karnani, Sudhakar Jha, Chih‐Ming Ho et al. · 2018 · Science Translational Medicine
51. A Fluorescent Carbon Nanotube Sensor Detects the Metastatic Prostate Cancer Biomarker uPA
    Ryan M. Williams, Christopher Lee, Daniel A. Heller · 2018 · ACS Sensors
52. miR‐142‐3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach‐1 expression
    Behzad Mansoori, Ali Mohammadi, Mehri Ghasabi, Solmaz Shirjang, Razeieh Dehghan, Vahid Montazeri, Uffe Holmskov, Tohid Kazemi, Pascal H. G. Duijf, Morten F. Gjerstorff et al. · 2018 · Journal of Cellular Physiology
53. A phase 2 trial of regorafenib as a single agent in patients with chemotherapy‐refractory, advanced, and metastatic biliary tract adenocarcinoma
    Weijing Sun, Anuj Kishor Patel, Daniel Paul Normolle, Krishna Patel, James P. Ohr, James J. Lee, Nathan Bahary, Edward Chu, Natalie R. Streeter, Summer Drummond · 2018 · Cancer
54. Sorafenib: key lessons from over 10 years of experience
    Bernard J. Escudier, Francis Paul Worden, Masatoshi Kudo · 2018 · Expert Review of Anticancer Therapy
55. MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis
    Jiu-Jie Cui, Zhu-Qing Zhou, Hai-Yan Yang, Feng Jiao, Ning Li, Yong Gao, Li-Wei Wang, Jing-De Chen, Ming Quan · 2019 · Molecular Cancer Research
56. A Technical Review of Convolutional Neural Network-Based Mammographic Breast Cancer Diagnosis
    Lian Zou, Shaode Yu, Tiebao Meng, Zhicheng Zhang, Xiaokun Liang, Yaoqin Xie · 2019 · Computational and Mathematical Methods in Medicine
57. Development and Validation of Novel Dietary and Lifestyle Inflammation Scores
    Doratha Armenthus Byrd, Suzanne E. Judd, W. Dana Flanders, Terryl J. Hartman, Veronika Fedirko, Roberd M. Bostick · 2019 · Journal of Nutrition
58. SANet: A Slice-Aware Network for Pulmonary Nodule Detection
    Jie Mei, Ming‐Ming Cheng, Gang Xu, Lan-Ruo Wan, Huan Zhang · 2021 · IEEE Transactions on Pattern Analysis and Machine Intelligence
59. Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances
    Lynda M. Vrooman, Lewis B. Silverman · 2016 · Current Hematologic Malignancy Reports
60. The Effect of Prophylactic Central Neck Dissection on Locoregional Recurrence in Papillary Thyroid Cancer After Total Thyroidectomy: A Systematic Review and Meta-Analysis
    Wenjing Zhao, Lei You, Xianming Hou, Shaobo Chen, Xiaoxia Ren, Ge Chen, Yupei Zhao · 2016 · Annals of Surgical Oncology
61. Biological determinants of radioresistance and their remediation in pancreatic cancer
    Parthasarathy Seshacharyulu, Michael J. Baine, Joshua J. Souchek, Melanie Menning, Sukhwinder Kaur, Ying Yan, Michel M. Ouellette, Maneesh Jain, Chi H. Lin, Surinder K. Batra · 2017 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
62. Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells
    Daniel A Luedtke, Xiaojia Niu, Yihang Pan, Jianyun Zhao, Shuang Liu, Holly J. Edwards, Kang Chen, Hai Lin, Jeffrey Warren Taub, Yubin Ge · 2017 · Signal Transduction and Targeted Therapy
63. Polymorphisms and expression pattern of circular RNA circ-ITCH contributes to the carcinogenesis of hepatocellular carcinoma
    Wenzhi Guo, Jiakai Zhang, Dongyu Zhang, Shengli Cao, Gongquan Li, Shuijun Zhang, Zhihui Wang, Peihao Wen, Han Yang, Xiaoyi Shi et al. · 2017 · Oncotarget
64. Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer
    Jia Wu, Bailiang Li, Xiaoli Sun, Guohong Cao, Daniel L. Rubin, Sandy A. Napel, Debra M. Ikeda, Allison W. Kurian, Ruijiang Li · 2017 · Radiology
65. Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas
    De‐Chen Lin, Huy Q. Dinh, Jian‐Jun Xie, Anand Mayakonda, Tiago C. Silva, Yan‐Yi Jiang, Ling‐Wen Ding, Jianzhong He, Xiu‐E Xu, Jia‐Jie Hao et al. · 2017 · Gut
66. Detection and classification of the breast abnormalities in digital mammograms via regional Convolutional Neural Network
    Mohammed A. Al‐masni, Mugahed A. Al–antari, J. M. Park, Geon Gi, T. Y. Kim, Patricio Rivera, E. Valarezo, Sola Han, T.-S. Kim · 2017 · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
67. Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U
    Xueying Yang, Chi Chiu Wang, Wayne Lee, Jone Trovik, Tony K.H. Chung, Joseph Kwong · 2017 · Cancer Letters
68. Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells
    Priya Samuel, Laura Ann Mulcahy, Fiona M. Furlong, Helen O. McCarthy, Susan Ann Brooks, Muller Fabbri, Ryan Charles Pink, David R. F. Carter · 2017 · Philosophical Transactions of the Royal Society B Biological Sciences
69. Psychological morbidity in family caregivers of people living with terminal cancer: Prevalence and predictors
    Neide P. Areia, G. Fonseca, S. Major, A. Relvas · 2018 · Palliative & Supportive Care
70. Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients With EGFR-Mutated Advanced Non–Small Cell Lung Cancer
    Aguiar, Pedro N., Haaland, Benjamin, Park, Wungki, San Tan, Pui, del Giglio, Auro, de Lima Lopes, Gilberto · 2018 · JAMA Oncology
71. Preoperative Monocyte-to-Lymphocyte Ratio in Peripheral Blood Predicts Stages, Metastasis, and Histological Grades in Patients with Ovarian Cancer
    Jiangdong Xiang, Lina Zhou, Xing Li, Wei Bao, Tai-Zhong Chen, Xiaowei Xi, Yinyan He, Xiaoping Wan · 2016 · Translational Oncology
72. Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study
    L. Kavalieris, P.J. O’Sullivan, Chris Frampton, Parry Guilford, David Darling, Elsie C. Jacobson, James M. Suttie, Jay D. Raman, Shahrokh François Shariat, Yair Lotan · 2016 · The Journal of Urology
73. Anaplastic lymphoma kinase (ALK) inhibitors in the treatment of ALK-driven lung cancers
    Robert Jr. Roskoski · 2017 · Pharmacological Research
74. Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment
    Javier Martínez‐Useros, Weiyao Li, Marticela Cabeza-Morales, Jesús García‐Foncillas · 2017 · Journal of Clinical Medicine
75. Pancreatic cancer-derived exosomes promote tumor metastasis and liver pre-metastatic niche formation
    Zeqian Yu, Susu Zhao, Long Fang Ren, Lishan Wang, Zhangjun Chen, Robert M. Hoffman, Jiahua Zhou · 2017 · Oncotarget
76. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer
    Ke Chen, Weikun Qian, Zhengdong Jiang, Liang Cheng, Jie Li, Liankang Sun, Cancan Zhou, Luping Gao, Meng Lei, Bin Yan et al. · 2017 · Molecular Cancer
77. Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests
    Kevin J. Selby, Christine Baumgartner, Theodore R. Levin, Chyke A. Doubeni, Ann Graham Zauber, Joanne Schottinger, Christopher D. Jensen, Jeffrey K. Lee, Douglas A. Corley · 2017 · Annals of Internal Medicine
78. Race Disparities in the Contribution of miRNA Isoforms and tRNA-Derived Fragments to Triple-Negative Breast Cancer
    Aristeidis G. Telonis, Isidore Rigoutsos · 2017 · Cancer Research
79. Defining the molecular pathology of pancreatic body and tail adenocarcinoma
    Australian Pancreatic Cancer Genome Initiative, Stephan B. Dreyer, Nigel Balfour Jamieson, Rosanna Upstill‐Goddard, Peter J. Bailey, C. J. McKay, Andrew Victor Biankin, David Kuang-Fu Chang · 2018 · British journal of surgery
80. β-Sitosterol targets Trx/Trx1 reductase to induce apoptosis in A549 cells via ROS mediated mitochondrial dysregulation and p53 activation
    Tamilselvam Rajavel, Pandian Packiyaraj, Venkatesan Suryanarayanan, Sanjeev Kumar Singh, Ruckmani Kandasamy, Kasi Pandima Devi · 2018 · Scientific Reports
81. CTGF Mediates Tumor–Stroma Interactions between Hepatoma Cells and Hepatic Stellate Cells to Accelerate HCC Progression
    Yuki Makino, Hayato Hikita, Takahiro Kodama, Minoru Shigekawa, Ryoko Yamada, Ryotaro Sakamori, Hidetoshi Eguchi, Eiichi Morii, Hideki Yokoi, Masashi Mukoyama et al. · 2018 · Cancer Research
82. Fucosylation in cancer biology and its clinical applications
    Ming Shan, Dandan Yang, Huaiqian Dou, Lijuan Zhang · 2019 · Progress in molecular biology and translational science
83. Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer
    Emily K. Kleczko, Jeff Kwak, Erin Lynn Schenk, Raphael A. Nemenoff · 2019 · Frontiers in Immunology
84. Incidence of atrial fibrillation in different major cancer subtypes: a Nationwide population-based 12 year follow up study
    C. Jakobsen, Morten Lamberts, Nicholas Carlson, Morten Lock‐Hansen, Christian Tobias Torp-Pedersen, Gunnar Gislason, Morten Schou · 2019 · BMC Cancer
85. Laser-assisted 3D bioprinting of exocrine pancreas spheroid models for cancer initiation study
    Davit Hakobyan, Chantal F. Medina, Nathalie Dusserre, Marie‐Laure Stachowicz, Charles Handschin, Jean‐Christophe Fricain, Julie Guillermet‐Guibert, Hugo Oliveira · 2020 · Biofabrication
86. Classifying non-small cell lung cancer types and transcriptomic subtypes using convolutional neural networks
    Kun‐Hsing Yu, Feiran Wang, Gerald J. Berry, Christopher Ré, Russ Biagio Altman, Michael P. Snyder, Isaac S. Kohane · 2020 · Journal of the American Medical Informatics Association
87. The Biogenesis and Functions of piRNAs in Human Diseases
    Xi Wu, Yutian Pan, Yuan Fang, Jingxin Zhang, Mengyan Xie, Fengming Yang, Tao Yu, Pei Ma, Wei Li, Yongqian Shu · 2020 · Molecular Therapy — Nucleic Acids
88. Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears
    Gila Lithwick‐Yanai, Nir Dromi, Alexander Shtabsky, Sara Morgenstern, Yulia Strenov, Meora Feinmesser, Vladimir Kravtsov, Marino E. Leon, Marián Hajdúch, Syed Zulfiqar Ali et al. · 2016 · Journal of Clinical Pathology
89. Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma
    Thomas Seisen, Ross Erik Krasnow, Joaquim Bellmunt B, Morgan Rouprêt A, Jeffrey Jia Jun Leow, Stuart R. Lipsitz, Malte W. Vetterlein, Mark A. Preston, Nawar Hanna, Adam Stuart Kibel et al. · 2017 · Journal of Clinical Oncology
90. Landscape of Combination Immunotherapy and Targeted Therapy to Improve Cancer Management
    Leandro Machado Colli, Mitchell J. Machiela, Han Zhang, Timothy A. Myers, Lea Jessop, Olivier Delattre, Kai F. Yu, Stephen Jacob Chanock · 2017 · Cancer Research
91. Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer
    Sai Kiran Sharma, Jacob Pourat, Dalya Abdel-Atti, Sean D. Carlin, Alessandra Piersigilli, Alexander J. Bankovich, Eric E. Gardner, Omar Hamdy, Kumiko Isse, Sheila Bheddah et al. · 2017 · Cancer Research
92. Metastatic renal cell carcinoma: Patterns and predictors of metastases—A contemporary population-based series
    Thenappan Chandrasekar, Zachary William Abraham Klaassen, Hanan Goldberg, Girish S. Kulkarni, Robert James Hamilton, Neil Eric Fleshner · 2017 · Urologic Oncology Seminars and Original Investigations
93. Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas
    Wanlu Du, Ivan Yu Jun Seah, Oumaima Bougazzoul, GiHun Choi, Katrina M. Meeth, Marcus Bosenberg, Hiroaki Wakimoto, David E. Fisher, Khalid Shah · 2017 · Proceedings of the National Academy of Sciences
94. SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway
    Weiwei Liu, Xuchu Wang, Zhenping Liu, Yiyun Wang, Binbin Yin, Yu Pan, Xiuzhi Duan, Zhaoping Liao, Yuhua Chen, Chunhua Liu et al. · 2017 · British Journal of Cancer
95. GFPT2 -Expressing Cancer-Associated Fibroblasts Mediate Metabolic Reprogramming in Human Lung Adenocarcinoma
    Weiruo Zhang, Gina Bouchard, Alice Yu, Mājid Shafiq, Mehran Jamali, Joseph B. Shrager, Kelsey Ayers, Shaimaa H. Bakr, Andrew J. Gentles, Maximilian Diehn et al. · 2018 · Cancer Research
96. Consumption of Sugars, Sugary Foods, and Sugary Beverages in Relation to Cancer Risk: A Systematic Review of Longitudinal Studies
    Nour Makarem, Elisa Victoria Bandera, Joey Nicholson, Niyati Parekh · 2018 · Annual Review of Nutrition
97. Technology, application and potential of dynamic breast thermography for the detection of breast cancer
    Jose-Luis Gonzalez-Hernandez, Alyssa N. Recinella, Satish G. Kandlikar, Donnette A. Dabydeen, Lori Medeiros, Pradyumna D. Phatak · 2018 · International Journal of Heat and Mass Transfer
98. Pharmacological Aspects and Potential Use of Phloretin: A Systemic Review
    Arokia Vijaya Anand Mariadoss, Ramachandran Vinayagam, Vinothkumar Rajamanickam, Vijayalakshmi Sankaran, Sathish Venkatesan, Ernest Kenechukwu David · 2019 · Mini-Reviews in Medicinal Chemistry
99. Symptoms in Children Receiving Treatment for Cancer—Part I: Fatigue, Sleep Disturbance, and Nausea/Vomiting
    Mary C. Hooke, Lauri A. Linder · 2019 · Journal of Pediatric Oncology Nursing
100. Diallyl Disulfide: A Bioactive Garlic Compound with Anticancer Potential
     Saikat Mitra, Rajib Chandra Das, Talha Bin Emran, Rafiuddin Khan Labib, Noor-E-Tabassum, Fahadul Islam, Rohit Sharma, Islamudin Ahmad, Firzan Nainu, Kumarappan Chidambaram et al. · 2022 · Frontiers in Pharmacology